CytoReason’s technology uses a machine learning model to build a molecular level understanding of tissues in diseases on the cellular level.
Read more here.
CytoReason’s technology uses a machine learning model to build a molecular level understanding of tissues in diseases on the cellular level.
Read more here.
![[CytoReason in Mobi Health News] Israeli startup CytoReason joins forces with Ferring Pharmaceuticals to find new IBD treatment](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
